Nirmal Bang: Biocon Q2 Review - Slowdown In Biologics Segment 
A technician works at Biocon facility in Bengaluru. (Photographer: Namas Bhojani/ Bloomberg)

Nirmal Bang: Biocon Q2 Review - Slowdown In Biologics Segment 

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer Bl...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.